Azenta Gestione

Gestione criteri di controllo 0/4

Azenta Il CEO è John P. Marotta, nominato in Sep2024, ha un mandato di meno di un anno. possiede direttamente 0.031% delle azioni della società, per un valore di $ 630.76K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 0.8 anni.

Informazioni chiave

John P. Marotta

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	0.03%
Durata media del management	1.8yrs
Durata media del Consiglio di amministrazione	less than a year

Aggiornamenti recenti sulla gestione

Recent updates

Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%

Nov 17

AMMINISTRATORE DELEGATO

John P. Marotta (43 yo)

less than a year

Mandato

Mr. John P. Marotta is President & CEO of Azenta, Inc. from September 9, 2024. Mr. Marotta serves as Executive in Residence at Patient Square Capital, LP since joining the firm in March 16, 2023. He levera...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jason Joseph	Senior VP	13.7yrs	US$1.44m	0.25% $ 5.1m
John P. Marotta	President & CEO	less than a year	Nessun dato	0.031% $ 630.8k
Lawrence Lin	Executive VP & CFO	no data	Nessun dato	Nessun dato
Violetta Hughes	VP & Chief Accounting Officer	1.3yrs	Nessun dato	0.0010% $ 20.8k
Michael Paulo	VP and Chief Information & Digital Officer	7.3yrs	Nessun dato	Nessun dato
Yvonne Perron	Vice President of Financial Planning & Analysis and Investor Relations	no data	Nessun dato	Nessun dato
John O'Brien	Senior Vice President of Corporate Development	14.5yrs	Nessun dato	Nessun dato
Olga Pirogova	Senior VP & Chief HR Officer	1.3yrs	Nessun dato	0.0024% $ 48.4k
J. Woodward	Senior Vice President of Global Quality & Regulatory	15yrs	Nessun dato	Nessun dato
Ginger Zhou	Senior VP and GM of the Genewiz Multiomics & Synthesis Solutions	5.5yrs	Nessun dato	0.021% $ 434.0k
David Wang	Senior VP & GM of Sample Management Solutions	1.8yrs	Nessun dato	0.014% $ 289.1k
Herman Cueto	Employee Advisor	no data	Nessun dato	0.0066% $ 134.8k

1.8yrs

Durata media

50yo

Età media

Gestione esperta: Il team dirigenziale di AZTA non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Tina Nova	Independent Director	1.8yrs	US$207.50k	0.013% $ 274.1k
Michael Rosenblatt	Independent Director	6.2yrs	US$260.00k	0.029% $ 589.0k
Martin Madaus	Independent Director	less than a year	Nessun dato	0.016% $ 334.4k
Didier Hirsch	Independent Director	less than a year	Nessun dato	0.0076% $ 156.4k
Alan Malus	Independent Director	no data	Nessun dato	0.0022% $ 44.9k
Edward Bousa	Independent Director	less than a year	Nessun dato	0.0054% $ 111.3k
Robyn Davis	Independent Vice Chair of the Board	11.4yrs	US$278.75k	0.065% $ 1.3m
William Cornog	Independent Director	no data	Nessun dato	0.032% $ 666.4k
Erica McLaughlin	Independent Director	4.6yrs	US$273.75k	0.028% $ 578.9k
Frank Casal	Independent Chairman	3yrs	US$275.00k	0.021% $ 424.1k
Quentin Koffey	Independent Director	no data	Nessun dato	0.0022% $ 44.9k

0.8yrs

Durata media

64yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di AZTA non è considerato esperto (durata media del mandato 0.8 anni), il che suggerisce un nuovo consiglio.

Azenta Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Independent Director recently bought US$495k worth of stock

Azenta, Inc. Announces Chief Financial Officer Changes

Azenta, Inc. Announces Management Changes

Stephen Schwartz to Retire as CEO of Azenta, Inc

Senior VP notifies of intention to sell stock

High number of new directors

Recent updates

Independent Director recently bought US$495k worth of stock

Consensus revenue estimates decrease by 14%

Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%

Price target decreased by 7.2% to US$56.60

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Full year 2024 earnings: EPS misses analyst expectations

Azenta, Inc. Announces Chief Financial Officer Changes

Azenta, Inc. to Report Q4, 2024 Results on Nov 12, 2024

Azenta, Inc Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

Azenta: Life Science Play Is Not Coming To Life

Azenta, Inc. Announces Management Changes

Price target decreased by 7.2% to US$58.25

Consensus EPS estimates fall by 29%

Forecast to breakeven in 2026

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

No longer forecast to breakeven

Azenta, Inc. to Report Q3, 2024 Results on Aug 06, 2024

Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon

Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024

Stephen Schwartz to Retire as CEO of Azenta, Inc

Azenta, Inc. to Report Q2, 2024 Results on May 08, 2024

Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?

Now 20% overvalued

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Consensus EPS estimates fall by 20%

New major risk - Revenue and earnings growth

Senior VP notifies of intention to sell stock

Consensus EPS estimates fall by 19%

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Azenta, Inc. Announces the Launch of the BioArc Ultra

Price target increased by 9.9% to US$72.00

Azenta, Inc. to Report Q1, 2024 Results on Feb 07, 2024

Azenta, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc

Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price

Azenta, Inc., Annual General Meeting, Jan 30, 2024

Key Executive notifies of intention to sell stock

Consensus EPS estimates fall by 14%

Consensus EPS estimates fall by 20%

Azenta, Inc. Provides Earnings Guidance for the Full Year Fiscal 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Azenta, Inc. to Report Q4, 2023 Results on Nov 13, 2023

Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?

Politan Capital Provides Information to the Shareholders

Consensus EPS estimates upgraded to US$0.39 loss

Azenta, Inc. Announces Chief Financial Officer Changes, Effective October 16, 2023

Politan Capital Management Engages in Discussions with Azenta

Politan Capital Management Engages in Discussions with Azenta

At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?

Now 23% undervalued

New minor risk - Insider selling

Insider recently sold US$407k worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Azenta, Inc. Revises Revenue Guidance for the Full Year of 2023

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Consensus EPS estimates upgraded to US$0.49 loss

Azenta, Inc. to Report Q3, 2023 Results on Aug 08, 2023

Now 20% undervalued

Independent Chairman notifies of intention to sell stock

Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?

Price target decreased by 13% to US$52.50

Forecast breakeven date pushed back to 2025

Consensus revenue estimates decrease by 11%

Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Azenta, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year 2023

Azenta, Inc. to Report Q2, 2023 Results on May 09, 2023